BSECompany Update6d ago · 12 Aug 2026, 07:28 pm
Undertaking for Non-Applicability of Reg 32
Kabra Drugs Ltd · 524322
✦ AI SummaryRegulatory
Kabra Drugs Ltd, now known as Aanjaay Industries Ltd, has submitted an undertaking to the BSE stating that Regulation 32 of SEBI (LODR) Regulations, 2015 is not applicable to the company for the quarter ended 30th June 2026. The company has not issued any shares through public issue, rights issue, or preferential issue during this period.
Analysis Scores
Earnings Impact5/10
Growth Catalyst5/10
Governance Concern2/10
Regulatory Risk8/10
Balance Sheet Risk5/10
Liquidity Impact5/10
Market Sentiment5/10
✦ Ask a Question
Ask anything about this announcement — AI will answer based on the filing content.
Full Announcement
Kabra Drugs Ltd - 524322 - Undertaking For Non- Applicability Of Regulation 32 Of SEBI
Attachments (1)
📄pdf
Download →
9f857f7b-23e5-4f7a-bec2-4b52d12ec273.pdf
View document text
Aanjaay Industries Limited
(Formerly known as Kabra Drugs Limited)
Vs CIN NO : L02423MP1989PLC005438
Regd Off: 208, Swadesh Bhavan, 2 Press Complex, AB Road, Indore, Madhya Pradesh — 452 011. Phone : +91 9884624100
Date: 12" August 2026
BSE Limited
Phiroze Jeejeebhoy Towers
21%* Floor, Dalal Street
Mumbai - 400001
BSE Scrip Code: 524322
Sub: Undertaking for Non- Applicability of Regulation 32 of SEBI (LODR)
Regulations, 2015 for the quarter ended on 30™ June 2026.
Dear Sir/Madam,
As per Regulation 32 of the SEBI (Listing Obligations and Disclosure Requirements)
Regulations, 2015 the listed entity shall submit to the stock exchange the following
statement(s) for quarter ended on 30" June 2026 for public issue, rights issue, preferential
i1ssue etc. —
(a) Indicating deviations, if any, in the use of proceeds from the objects stated in the offer
document or explanatory statement to the notice for the general meeting, as applicable;
(b) Indicating category wise variation (capital expenditure, sales and marketing, working
capital etc.) between projected utilization of funds made by it in its offer document or
explanatory statement to the notice for the general meeting, as applicable and the actual
utilization of funds.
In view of the aforesaid, I, the undersigned, Mr. Nanjappan Aravind, Managing Director
of Aanjaay Industries Limited (Formerly known as Kabra Drugs Limited) hereby certify
that Compliances of Regulation 32 of SEBI (LODR) Regulations, 2015 is not applicable to
the company as the company has not issued any share by way of public issue, right
issue, preferential issue etc. for the quarter ended on 30" June 2026.
Kindly take the aforesaid information on record and oblige.
Thanking you,
Yours sincerely,
For Aanjaay Industries Limited
(Formerly known as Kabra Drugs Limited)
NANJAPPA \Zaoa arvin
N ARAVIND 757575 o550
Nanjappan Aravind
Managing Director
DIN: 01895602
Corp.Off : No.3, 2™ Floor, Swaminathan Street, West Mambalam, Chennai, 600 033
Phone : +91 - 44 - 4356 4679 Emalil : aanjaayindustries@gmail.com